David Bikard
Title
Cited by
Cited by
Year
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
W Jiang, D Bikard, D Cox, F Zhang, LA Marraffini
Nature biotechnology 31 (3), 233-239, 2013
20862013
Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system
D Bikard, W Jiang, P Samai, A Hochschild, F Zhang, LA Marraffini
Nucleic acids research 41 (15), 7429-7437, 2013
8722013
Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials
D Bikard, CW Euler, W Jiang, PM Nussenzweig, GW Goldberg, X Duportet, ...
Nature biotechnology 32 (11), 1146-1150, 2014
5812014
Cas9 specifies functional viral targets during CRISPR–Cas adaptation
R Heler, P Samai, JW Modell, C Weiner, GW Goldberg, D Bikard, ...
Nature 519 (7542), 199-202, 2015
3322015
CRISPR interference can prevent natural transformation and virulence acquisition during in vivo bacterial infection
D Bikard, A Hatoum-Aslan, D Mucida, LA Marraffini
Cell host & microbe 12 (2), 177-186, 2012
3302012
Divergent evolution of duplicate genes leads to genetic incompatibilities within A. thaliana
D Bikard, D Patel, C Le Metté, V Giorgi, C Camilleri, MJ Bennett, O Loudet
Science 323 (5914), 623-626, 2009
2842009
Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting
GW Goldberg, W Jiang, D Bikard, LA Marraffini
Nature 514 (7524), 633-637, 2014
2242014
Conjugative DNA transfer induces the bacterial SOS response and promotes antibiotic resistance development through integron activation
Z Baharoglu, D Bikard, D Mazel
PLoS Genet 6 (10), e1001165, 2010
2002010
PhageTerm: a tool for fast and accurate determination of phage termini and packaging mechanism using next-generation sequencing data
JR Garneau, F Depardieu, LC Fortier, D Bikard, M Monot
Scientific reports 7 (1), 1-10, 2017
1832017
Folded DNA in action: hairpin formation and biological functions in prokaryotes
D Bikard, C Loot, Z Baharoglu, D Mazel
Microbiology and Molecular Biology Reviews 74 (4), 570-588, 2010
1572010
Consequences of Cas9 cleavage in the chromosome of Escherichia coli
L Cui, D Bikard
Nucleic acids research 44 (9), 4243-4251, 2016
1492016
CRISPR-Cas component systems, methods and compositions for sequence manipulation
F Zhang
US Patent 9,840,713, 2017
1472017
Crispr-cas component systems, methods and compositions for sequence manipulation
F Zhang, DBT Cox, L Marraffini, DO Bikard, W Jiang
US Patent App. 14/497,627, 2015
1262015
Crispr-cas component systems, methods and compositions for sequence manipulation
F Zhang, L Cong, DBT Cox, P Hsu, LIN Shuailiang, RAN Fei, RJ Platt, ...
US Patent App. 14/105,035, 2014
1252014
Innate and adaptive immunity in bacteria: mechanisms of programmed genetic variation to fight bacteriophages
D Bikard, LA Marraffini
Current opinion in immunology 24 (1), 15-20, 2012
1072012
A CRISPRi screen in E. coli reveals sequence-specific toxicity of dCas9
L Cui, A Vigouroux, F Rousset, H Varet, V Khanna, D Bikard
Nature communications 9 (1), 1-10, 2018
1012018
Adapting to new threats: the generation of memory by CRISPR‐Cas immune systems
R Heler, LA Marraffini, D Bikard
Molecular microbiology 93 (1), 1-9, 2014
992014
Genome-wide CRISPR-dCas9 screens in E. coli identify essential genes and phage host factors
F Rousset, L Cui, E Siouve, C Becavin, F Depardieu, D Bikard
PLoS genetics 14 (11), e1007749, 2018
822018
Using CRISPR-Cas systems as antimicrobials
D Bikard, R Barrangou
Current opinion in Microbiology 37, 155-160, 2017
672017
Crispr-cas component systems, methods and compositions for sequence manipulation
F Zhang, DBT Cox, L Marraffini, DO Bikard, W Jiang, NE Sanjana
US Patent App. 15/887,377, 2018
642018
The system can't perform the operation now. Try again later.
Articles 1–20